Skip to main content Help with accessibility Skip to main navigation

ESKETAMINE nasal spray (Spravato®▼) for short-term treatment of a psychiatric emergency due to Major Depressive Disorder

CCG Approval Status:

Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 25 - Mar - 2021
Body System:
Grey
ESKETAMINE nasal spray (Spravato®▼) for short-term treatment of a psychiatric emergency due to Major Depressive Disorder

The Pan Mersey Area Prescribing Committee does not currently recommend the prescribing of ESKETAMINE nasal spray (Spravato®▼) for short-term treatment of a psychiatric emergency due to Major Depressive Disorder.